Skip to main content
. 2015 Sep 22;11:28. doi: 10.1186/s12993-015-0074-8

Fig. 7.

Fig. 7

The effect of 4OGOMV on the polyclonal NeuN, BrdU and GFAP immunostaining among the SAH groups. Upper panel: NeuN(+) neurons (red arrow head) with vaculated neucli and groups were depicted as: a Sham-operated; b SAH group and c 400 μg/kg/day 4OGOMV treatment SAH group.(n = 9/group) Middle and lower panels shows the BrdU(+) (black arrow head) and GFAP(+) cells (yellow arrow head) respectively.(X200) Standard bar = 100 μm